ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ONC Oncimmune Holdings Plc

21.20
0.20 (0.95%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oncimmune Holdings Plc LSE:ONC London Ordinary Share GB00BYQ94H38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.95% 21.20 20.60 22.00 21.00 21.00 21.00 12,949 16:35:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 1.47M -6.15M -0.0830 -2.53 15.57M

Oncimmune Holdings PLC Notice of AGM (9078O)

03/02/2023 11:50am

UK Regulatory


Oncimmune (LSE:ONC)
Historical Stock Chart


From Mar 2022 to Mar 2024

Click Here for more Oncimmune Charts.

TIDMONC

RNS Number : 9078O

Oncimmune Holdings PLC

03 February 2023

3 February 2023

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Notice of Annual General Meeting

Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, today gives notice that its Annual General Meeting ("AGM") will be held at 10:00am GMT on 27 February 2023 at the offices of Pinsent Masons LLP, 30 Crown Place, Earl Street, London, EC2A 4ES.

The Notice of AGM will be sent to shareholders today and can also be viewed on the "Investors" section of the Company's website at www.oncimmune.com .

For further information:

Oncimmune Holdings plc

Dr Adam M Hill, Chief Executive Officer

Matthew Hall, Chief Financial Officer

contact@oncimmune.co.uk

Singer Capital Markets (Nominated Adviser and Joint Broker)

Aubrey Powell, Harry Gooden, George Tzimas, James Fischer

+44 (0)20 7496 3000

WG Partners (Joint Broker)

David Wilson, Nigel Barnes, Erland Sternby

+44 (0)20 3705 9321

For more information, visit www.oncimmune.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOANKNBQDBKDCBK

(END) Dow Jones Newswires

February 03, 2023 06:50 ET (11:50 GMT)

1 Year Oncimmune Chart

1 Year Oncimmune Chart

1 Month Oncimmune Chart

1 Month Oncimmune Chart

Your Recent History

Delayed Upgrade Clock